Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $1.52 billion. The enterprise value is $1.22 billion.
| Market Cap | 1.52B |
| Enterprise Value | 1.22B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 17.96 million shares outstanding. The number of shares has increased by 0.82% in one year.
| Shares Outstanding | 17.96M |
| Shares Change (YoY) | +0.82% |
| Shares Change (QoQ) | +2.52% |
| Owned by Insiders (%) | 2.35% |
| Owned by Institutions (%) | 95.52% |
| Float | 17.55M |
Valuation Ratios
The trailing PE ratio is 15.94 and the forward PE ratio is 18.48. LGND's PEG ratio is 1.53.
| PE Ratio | 15.94 |
| Forward PE | 18.48 |
| PS Ratio | 12.87 |
| Forward PS | 11.16 |
| PB Ratio | 1.89 |
| P/FCF Ratio | n/a |
| PEG Ratio | 1.53 |
Enterprise Valuation
| EV / Earnings | 12.65 |
| EV / Sales | 10.30 |
| EV / EBITDA | 7.67 |
| EV / EBIT | 9.98 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.71, with a Debt / Equity ratio of 0.01.
| Current Ratio | 20.71 |
| Quick Ratio | 19.03 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | 219.26 |
Financial Efficiency
Return on equity (ROE) is 13.60% and return on invested capital (ROIC) is 0.07%.
| Return on Equity (ROE) | 13.60% |
| Return on Assets (ROA) | 11.90% |
| Return on Capital (ROIC) | 0.07% |
| Revenue Per Employee | $2.04M |
| Profits Per Employee | $1.66M |
| Employee Count | 58 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 0.55 |
Taxes
In the past 12 months, LGND has paid $25.23 million in taxes.
| Income Tax | 25.23M |
| Effective Tax Rate | 20.75% |
Stock Price Statistics
The stock price has increased by +16.68% in the last 52 weeks. The beta is 0.92, so LGND's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +16.68% |
| 50-Day Moving Average | 80.34 |
| 200-Day Moving Average | 70.34 |
| Relative Strength Index (RSI) | 59.19 |
| Average Volume (20 Days) | 120,050 |
Short Selling Information
The latest short interest is 936,637, so 5.21% of the outstanding shares have been sold short.
| Short Interest | 936,637 |
| Short Previous Month | 707,718 |
| Short % of Shares Out | 5.21% |
| Short % of Float | 5.34% |
| Short Ratio (days to cover) | 7.61 |
Income Statement
In the last 12 months, LGND had revenue of $118.31 million and earned $96.34 million in profits. Earnings per share was $5.32.
| Revenue | 118.31M |
| Gross Profit | 108.64M |
| Operating Income | 725,000 |
| Pretax Income | 121.57M |
| Net Income | 96.34M |
| EBITDA | 158.80M |
| EBIT | 122.13M |
| Earnings Per Share (EPS) | $5.32 |
Balance Sheet
The company has $310.59 million in cash and $6.19 million in debt, giving a net cash position of $304.40 million or $16.95 per share.
| Cash & Cash Equivalents | 310.59M |
| Total Debt | 6.19M |
| Net Cash | 304.40M |
| Net Cash Per Share | $16.95 |
| Equity (Book Value) | 806.52M |
| Book Value Per Share | 44.90 |
| Working Capital | 351.10M |
Cash Flow
In the last 12 months, operating cash flow was $34.36 million and capital expenditures -$51.25 million, giving a free cash flow of -$16.89 million.
| Operating Cash Flow | 34.36M |
| Capital Expenditures | -51.25M |
| Free Cash Flow | -16.89M |
| FCF Per Share | -$0.95 |
Margins
Gross margin is 91.82%, with operating and profit margins of 0.61% and 81.43%.
| Gross Margin | 91.82% |
| Operating Margin | 0.61% |
| Pretax Margin | 102.75% |
| Profit Margin | 81.43% |
| EBITDA Margin | 134.22% |
| EBIT Margin | 103.22% |
| FCF Margin | -14.28% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.82% |
| Shareholder Yield | -0.82% |
| Earnings Yield | 6.33% |
| FCF Yield | -1.11% |
Analyst Forecast
The average price target for LGND is $116.33, which is 37.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $116.33 |
| Price Target Difference | 37.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 17.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 2, 2022. It was a forward split with a ratio of 1603:1000.
| Last Split Date | Nov 2, 2022 |
| Split Type | Forward |
| Split Ratio | 1603:1000 |
Scores
LGND has an Altman Z-Score of 10.45 and a Piotroski F-Score of 6.
| Altman Z-Score | 10.45 |
| Piotroski F-Score | 6 |